CVE-2023-34334

CVE-2023-34334 is a high-severity vulnerability in Ami Megarac Sp-x with a CVSS 3.x base score of 7.2. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

AMI BMC contains a vulnerability in the SPX REST API, where an attacker with the required privileges can inject arbitrary shell commands, which may lead to code execution, denial of service, information disclosure, or data tampering.

Frequently asked questions

What is CVE-2023-34334?
AMI BMC contains a vulnerability in the SPX REST API, where an attacker with the required privileges can inject arbitrary shell commands, which may lead to code execution, denial of service, information disclosure, or data tampering.
How severe is CVE-2023-34334?
CVE-2023-34334 has a CVSS 3.x base score of 7.2, rated high severity. It is exploitable over network with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-34334 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (53rd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-34334?
CVE-2023-34334 affects Ami Megarac Sp-x. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-34334?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-34334 published?
CVE-2023-34334 was published on 2023-06-12 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Ami Megarac Sp-x

All CVEs affecting Ami Megarac Sp-x →

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →